INSTRUCTIONS FOR ABSTRACT PREPARATION

Annual Scientific Meeting of the American College

of Veterinary Anesthesiologists

Please read the following instructions carefully. All abstracts must be typed on the enclosed form unless the abstract form on disk is used or the abstract is submitted by electronic mail. The abstract form is available on disk as a file in Word Perfect 10.0⁷ and Microsoft Word for those who wish to use it during preparation of their abstract. Those individuals should send a blank disk to Dr. Riebold for that file or contact him to arrange electronic transfer of the file. He can be reached at thomas.riebold@oregonstate.edu. The abstract form is also available as a file on the American College of Veterinary Anesthesiologists web site. That location is http://www.acva.org.

I. GENERAL INFORMATION

A. The abstract, if accepted for presentation at the meeting, will be printed as submitted if no editorial changes are required.

B. Because the abstract deadline is relatively late to allow notification of acceptance to authors in time for travel arrangements to be made, it is important that authors respond to questions posed by the reviewers in a timely fashion.

II. FORMAT

A. The entire abstract must fit within the box on the enclosed form or fit within a text box approximately 5.5" wide by 5.75" high. Average abstract length is about 250-300 words. No more than one page per abstract will be printed in the proceedings.

B. The abstract should contain the following sections, title, authors, and abstract body in sequence. An example is enclosed.

C. Title: The title should be brief and must accurately reflect the content of the abstract. Abbreviations must not be used in the abstract title. Capitalize the entire title. The subject index is developed from words used in the title; choose them carefully.

D. Authors: List initials and last name of each author along with institutional affiliation, city, and state. Underline only the presenting author's name. If no institution is involved, list city and state. Omit degrees, titles, institutional appointments, street address, and zip code. Indicate ACVA diplomate status by an asterisk. Asterisks may not be used as symbols except to denote ACVA diplomates. Do not identify granting agencies that may have supported the study.

E. Abstract Body: The preferred format is: Introduction, Materials and Methods, Results, and Conclusions/Discussion. Subheadings should not be used to denote these sections in the abstract. If this format is not appropriate for your abstract, flowing text or other modification is acceptable. Underlining or capitalization for emphasis in text is unacceptable. Single space all typing with no space between titles and body or between paragraphs. Indent each paragraph three spaces. Do not indent the title. Use an appropriate printer font for Greek and math symbols.

1. Introduction: A statement of the purpose of the study should be made in one or two sentences.

2. Materials and Methods: The materials and methods used in the study should be provided. Nonproprietary names are required whenever a drug is mentioned. If space allows, it is preferred that the method of statistical analysis be given.

3. Results: Data should be presented in sufficient detail to support the conclusions. Tables or charts should not be included. Data should be presented either as mean values with one statistical difference or as mean values with one standard error of mean. All changes should be presented as mean increases or decreases with one statistical difference or standard error of mean. Statistical significance should be noted. It is not satisfactory to state "Results will be discussed" or "Other data will be presented."

4. Discussion: This section should include an interpretation of the findings and any conclusions that can be drawn. Avoid restatement of results.

5. Other: When used, abbreviations should be capitalized. Commonly used abbreviations may be used without definition if the author chooses. Some abbreviations may be unfamiliar to a large number of readers; at the author's discretion, these should be defined. Abbreviations should be defined by placing them in parentheses after the term the first time the term appears in the body of the abstract. Use numerals to indicate numbers except when beginning sentences.

3. PRINTING / TYPING INSTRUCTIONS

A. To maintain readability during the review process, the abstract should be printed with 12 point Courier, letter Gothic, Times Roman, or similar font. Do not use fonts that simulate script. Use totally uniform spacing between lines and do not squeeze any line of the abstract. If necessary, the final line may touch the line border or 11 point Courier, letter Gothic, Times Roman, or similar font may be used. If smaller font size (10 point or less) is required for the abstract to fit in the box, the abstract is probably too long and may have difficulty conforming to scientific journals' definition of an abstract. To maintain uniformity during publication, abstracts printed in something other than 12 point font should also be submitted on disk or via E-mail so that they may be converted to standard font for the proceedings.

B. Errors should be corrected by using correction tape/fluid, or similar product; or by reprinting the abstract. Additional abstract forms may be obtained from Dr. Riebold (Oregon State University) or the ACVA web site.

IV. MAILING INSTRUCTIONS

A. The abstract can be submitted electronically to Dr. Riebold or a printed copy of the abstract on the abstract form and two copies of the abstract for review can be mailed to Dr. Riebold. He will code the abstract, obscure the authors' names and addresses, and forward the abstracts to the ACVA Education Committee chair and other committee members for review.

B. Those who submit printed abstracts should send a copy of the abstract on disk to Dr. Riebold to enable any last minute editorial changes deemed necessary by the Education Committee to be made by telephone or E-mail.

C. Abstracts received after June 1, 2006 may not be considered for presentation if sufficient time for review and inclusion in the proceedings is unavailable.

D. Include in each mailing:

1. Cover letter

2. Original abstract

3. Two copies of original abstract. Circle or highlight three to six keywords for the proceedings index on one copy.

4. Please identify the abstract by checking the box on the abstract form if it is eligible for the residents' competition and you wish to have it entered in the competition.

5. A copy of the abstract on disk preferably as a Word Perfect⁷ or Word⁷ file or as an ASCII file. However, Macintosh files can be utilized if the author is using that platform. In lieu of submitting the abstract on disk, the file may be transmitted by E-mail to Dr. Riebold at thomas.riebold@oregonstate.edu.

6. Abstracts can be faxed to Dr. Riebold at 541-737-6879 or sent by electronic mail in order to meet the deadline. However, a copy of the abstract on disk should be submitted by mail soon after the abstract is faxed. Express delivery of the disk and printed copy of the abstract following fax submission is not warranted for the review process to begin if the author places those materials in the mail in a timely fashion. If abstract submission is occurring through fax communication, please contact Dr. Riebold [voice mail (541-737-6951) or E-mail (thomas.riebold@oregonstate.edu)] to make him aware that the abstract will arrive in that manner.

ABSTRACT PREPARATION CHECK LIST

Annual Scientific Meeting of the American College of Veterinary Anesthesiologists

Before mailing, please check your abstract for the following common errors:

9 Be certain that the TITLE is completely capitalized.

9 Do not use an abbreviation in the title and do not indent the title.

9 The name of the author who will present the abstract must be underlined.

9 Initials or first names must precede the authors' last name.

9 Be sure asterisks are used only to designate ACVA diplomates.

9 Institutional affiliation, city, and state are required.

9 Do not include degrees, street address, zip code, and grant support in the abstract.

9 Do not begin author's name or address on a new line unless necessary.

9 Begin the body of the abstract on a new line which is indented three spaces.

9 Do not use subheadings, illustrations, references, or tables in the abstract body.

9 Do not use unacceptable abbreviations. Define uncommon abbreviations in the abstract.

9 Asterisks are not to be used as reference symbols except to denote ACVA diplomate status.

9 The abstract must stay within the rectangular borders with the left hand border straight. If using less than 12 point font size in order for the abstract to fit in the box, be sure that the abstract is not too long (>450 words) and in jeopardy of being considered as already published when the full paper is submitted to a journal.

9 Do not squeeze letters or lines.

9 Smudges or faint printing/typing may require reprinting/retyping of the abstract.

9 Do not use capital letters or underlining for emphasis.

9 Check accuracy of spelling and hyphenation.

9 There should be no space between lines or paragraphs.

9 A conclusion must be stated. Promise of additional data or discussion is not acceptable.

Send the completed abstract form, two copies of the abstract (one copy with keywords designated), and the abstract on disk to Dr. Riebold by June 1, 2006.

AMERICAN COLLEGE OF VETERINARY ANESTHESIOLOGISTS

ABSTRACT FORM

1. Title of Abstract: INHALED CARBON MONOXIDE CONCENTRATION DURING HALOTHANE

OR ISOFLURANE ANESTHESIA IN HORSES.

2. This abstract is submitted by: University of Missouri

(Name of organization)

3. Names of Authors: Presenting author a) JR Dodam

Other authors b) KR Branson

c) ME Gross

d) D Sanders

e) GF Petroski

4. Name, complete address, and phone numbers of presenting author:

Name John R. Dodam DVM, PhD

Address Department of Veterinary Medicine and Surgery

College of Veterinary Medicine

University of Missouri

Columbia, Missouri 65211

Phone (573) 882‑7821 FAX: (573) 884‑5444 E-Mail: dodam@vets.vetmed.missouri.edu

5. This abstract is eligible for and I wish to have it entered in the Residents' competition. Yes 9 No :

Type abstract here. Be sure to stay within border.

INHALED CARBON MONOXIDE CONCENTRATION DURING HALOTHANE OR ISOFLURANE ANESTHESIA IN HORSES. JR Dodam,* KR Branson,* ME Gross,* D Sanders, GF Petroski. University of Missouri, Columbia, MO.

Interaction between volatile anesthetics and CO₂ absorbents may result in production of carbon monoxide (CO). The purpose of this study was to assess CO exposure during equine anesthesia with either halothane (H; n = 26) or isoflurane (I; n = 24). Clinical cases were randomly assigned to receive either H or I. Two anesthetic machines were used and assigned to a single agent for 2-4 weeks. Machines were disassembled, and soda lime replaced whenever agents were switched. Soda lime was otherwise replaced as needed. Gas samples were continuously withdrawn from the inspiratory limb of the circuit and directed to an electrochemical detector for CO measurement. Values were recorded at 15 minute intervals for 90 minutes. Data were analyzed using a five-factor ANOVA with repeated measures. Inspired CO concentration for H and I, respectively, increased from 1 " 1 and 6 " 2 ppm at baseline to 54 " 10 and 21 " 6 ppm at 90 minutes (mean " SEM). H was associated with significantly greater CO concentrations than I at 30-90 minutes, although CO at baseline was significantly greater in the I group than the H group. O₂ flow rates were 9.9 " 0.1 liters/minute at baseline for H and I, and 5.0 " 0.1 and 5.0 " 0.2 liters/minute at 90 minutes for H and I, respectively. There were no significant differences in oxygen flow at any time point. Neither mechanical ventilation nor new vs used soda lime affected concentration of CO.

Check Single Subspecialty

Classification:

Acid-Base Balance.................................

Analgesia.................................................

Anesthetic Complications

& Emergencies.....................................

Anesthetic Equipment........................... x

Clinical Epidemiology.............................

Critical Care..............................................

Euthanasia...............................................

Exotic Animals.........................................

Injectable Anesthetic Techniques.......

Inhalation Anesthesia............................

Monitoring Equipment/Techniques....

Muscle Relaxants....................................

Patient Evaluation & Care.....................

Pharmacokinetics....................................

Pharmacology/Physiology....................

a. Cardiovascular................................

b. Endocrinology................................

c. Gastroenterology............................

d. Hematology.....................................

e. Immunology....................................

f. Metabolism......................................

g. Neurology........................................

h. Pulmonary........................................

i. Renal & Electrolyte........................

j. Other.................................................

Records & Statistics...............................

Recovery

Regional/Local Anesthesia...................

Restraint Techniques.............................

Resuscitation...........................................

Sedation/Tranquilization.......................

Other (specify)........................................

____________________________

____________________________

SIGNATURE

(Presenting Author)